The Effect of Proton Pump-Inhibiting Drugs on Mineral Metabolism

被引:55
作者
Insogna, Karl L. [1 ]
机构
[1] Yale Univ, Dept Med, Endocrine Sect, New Haven, CT 06520 USA
关键词
TERM OMEPRAZOLE TREATMENT; GASTRIC-ACID SECRETION; CALCIUM-ABSORPTION; CARBONATE; PHOSPHATE; HUMANS; RISK;
D O I
10.1038/ajg.2009.44
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Two recent studies have reported increased hip fracture rates with long-term proton pump inhibitor (PPI) use raising concerns about adverse effects of this class of drugs on mineral metabolism. One plausible mechanism by which PPIs could affect calcium economy and skeletal homeostasis is by impairing intestinal calcium absorption. In the long term, this could potentially lead to a negative whole body calcium balance, resulting in higher rates of bone loss and a greater risk of fragility fractures.
引用
收藏
页码:S2 / S4
页数:3
相关论文
共 12 条
[1]   Bone mineral density in patients taking H2-receptor antagonist [J].
Adachi, Y ;
Shiota, E ;
Matsumata, T ;
Iso, Y ;
Yoh, R ;
Kitano, S .
CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (04) :283-285
[2]   Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload - Role of gastric acid secretion [J].
Graziani, G ;
Badalamenti, S ;
Como, G ;
Gallieni, M ;
Finazzi, S ;
Angelini, C ;
Brancaccio, D ;
Ponticelli, C .
NEPHRON, 2002, 91 (03) :474-479
[3]  
GRAZIANI G, 1995, NEPHROL DIAL TRANSPL, V10, P1376
[4]   Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis [J].
Hardy, P ;
Sechet, A ;
Hottelart, C ;
Oprisiu, R ;
Abighanem, O ;
Said, S ;
Rasombololona, M ;
Brazier, M ;
Moriniere, P ;
Achard, JM ;
Pruna, A ;
Fournier, A .
ARTIFICIAL ORGANS, 1998, 22 (07) :569-573
[5]   Proton pump inhibitor use and risk of hip fractures in patients without major risk factors [J].
Kaye, James A. ;
Jick, Hershel .
PHARMACOTHERAPY, 2008, 28 (08) :951-959
[6]   Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children [J].
Kocsis, I ;
Arató, A ;
Bodánszky, H ;
Szönyi, L ;
Szabó, A ;
Tulassay, T ;
Vásárhelyi, B .
CALCIFIED TISSUE INTERNATIONAL, 2002, 71 (02) :129-132
[7]   EFFECT OF OMEPRAZOLE, AN INHIBITOR OF H+, K+-ATPASE, ON BONE-RESORPTION IN HUMANS [J].
MIZUNASHI, K ;
FURUKAWA, Y ;
KATANO, K ;
ABE, K .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (01) :21-25
[8]   Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial [J].
O'Connell, MB ;
Madden, DM ;
Murray, AM ;
Heaney, RP ;
Kerzner, LJ .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (07) :778-781
[9]   CALCIUM-ABSORPTION AND ACHLORHYDRIA [J].
RECKER, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (02) :70-73
[10]  
SERFATYLACROSNIERE C, 1995, J AM COLL NUTR, V14, P364